Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases

Pulmonary Arterial Hypertension associated with Protein Kinase Inhibitors: A pharmacovigilance-pharmacodynamic study

(2019) L. Cornet et al.   EUROPEAN RESPIRATORY JOURNAL

Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review

(2019) Guillermo Prada-Ramallal et al.   BMC Medical Research Methodology

Harms are assessed inconsistently and reported inadequately Part 1: Systematic adverse events

(2019) Evan Mayo-Wilson et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Pleural adverse drugs reactions and protein kinase inhibitors: identification of suspicious targets by disproportionality analysis from VigiBase®

(2018) Julien Mahé et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems

(2018) E. Raschi et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders

(2016) Thi Thu Ha Nguyen et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Good Signal Detection Practices: Evidence from IMI PROTECT

(2016) Antoni F. Z. Wisniewski et al.   DRUG SAFETY

Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase®

(2016) François Montastruc et al.   DRUG SAFETY

Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes

(2016) Suetonia C. Palmer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

(2016) Andrea Cipriani et al.   LANCET

Indication bias or protopathic bias?

(2015) Jean-Luc Faillie   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies

(2015) Miguel-Angel Maciá-Martínez et al.   DRUG SAFETY

A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases

(2015) Mickael Arnaud et al.   DRUG SAFETY

Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations

(2015) Chirag J. Patel et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis

(2015) Suetonia C Palmer et al.   LANCET

The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010

(2014) Keith B. Hoffman et al.   DRUG SAFETY

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area

(2014) Birgitta Grundmark et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Systematic reviews published in higher impact clinical journals were of higher quality

(2014) Padhraig S. Fleming et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews

(2014) P. Saini et al.   BMJ-British Medical Journal

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases

(2013) Francois Maignen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Effect of Competition Bias in Safety Signal Generation

(2012) Antoine Pariente et al.   DRUG SAFETY

Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

(2011) Jean-Louis Montastruc et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development

(2011) S Schneeweiss et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Defining ‘Signal’ and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous Definitions

(2009) Manfred Hauben et al.   DRUG SAFETY